Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy

Bratislava Medical Journal

Volumn 110, Issue 9, 2009, Pages 559-562

  Ziaran, S ^a   Goncalves, F M ^a   Wendl, J ^a   Trebaticky, B ^a   Sn, Breza J ^a  

^a Bratislava   (Slovakia)

Author keywords

Androgen deprivation therapy; Osteopenia; Osteoporosis in men; Prostate cancer

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; BONE DENSITY; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PROSTATE TUMOR;

ABSORPTIOMETRY, PHOTON; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE DENSITY; HUMANS; MALE; OSTEOPOROSIS; PROSTATIC NEOPLASMS;

EID: 75649091847     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
2. Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab 1999; 84: 3431-3434.
3. Kanis J, Melton III L, Christiansen C, Johnston C, Khaltaev N. Perspective: the diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
4. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997; 12: 1761-1768.
5. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002; 162: 2217-2222.
6. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002; 162: 2217-2222.
7. Eastell R. Treatment of postmenopausal osteoporosis. New Engl J Med 1998; 338: 736-746.
8. Grampp S, Jergas M, Gluer CC, Lang P, Brastow P, Genant HK. Radiologic diagnosis of osteoporosis. Current methods and perspectives. Radiol Clin North Am 1993; 31: 1133-1145.
9. Bateman C. South Africa under-prioritises osteoporosis. S Afr Med J 2006; 96: 19-20.
10. Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. J Amer Med Ass 2007; 298: 629-637.
11. Smith MR. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer 2003; 97: 789-795.
12. Orwoll ES, Klein RF. Osteoporosis in men. Endocrine Reviews 1995; 16: 87-116.
13. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Amer J Med 1993; 94: 646-650.
14. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002; 359: 1841-1850.
15. Boonen S, Vanderschueren D. Bone loss and osteoporotic fracture occurrence in aging men. 455-462. In: Lunenfeld B, Gooren L (Eds). Textbook of Men's Health. New York, Parthenon Publishing Group, 2002.
16. Liska J, Repiska V, Galbavy S, Polak S, Varga I, Blasko M, Macejova D, Brtko J. Prostate tumors histological classification and molecular aspects of prostate tumorigenesis. Endocrine Regulation 2007; 41: 45-57.
17. Huggins C, Hodges CV. Studies on prostatic cancer II: the effects of castration on advanced carcinoma of the prostate gland. Arch Surg 1941; 43: 209-223.
18. Morote J, Morin JP, Orsola A, Abascal JM, Salvador C, Trilla E, Raventos CX, Cecchini L, Encabo G, Reventos J. Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer. Urology 2007; 69(3): 500-504.
19. Planas J, Morote J, Orsola A, Salvador C, Trilla E, Cecchini L, Raventós CX. The relationship between daily calcium intake and bone mineral density in men with prostate cancer BJU Int 2007;99(4): 812-815.
20. Abrahamsen B, Nielsen MF, Eskildsen P, Andersen JT, Walter S, Brixen K. Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int 2007; 100(4): 749-754.
21. Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. Urology 2004; 64(2): 335-340.
22. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-156.
23. Scopacasa F, Horowitz M, Wishart JM, Morris HA, Chatterton BE, Need AG. The relation between bone density, free androgen index, and estradiol in men 60 to 70 years old. Bone 2000; 27: 145-149.
24. Bruder JM, Ma JZ, Basler JW, Welch MD. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy. Urology 2006; 67(1): 152-155.
25. Agarwal MM, Khandelwal N, Mandal AK, Rana SV, Gupta V, Chandra Mohan V, Kishore GV. Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy. Cancer 2005; 103(10): 2042-2052.
26. Malkowicz SB, Chu F, Forrest J, Smith MR, Price D, Sieber P, Barnette KG, Rodriguez D, Steiner MS. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(8S): 5116.
27. Cummings SR, Black DM, Nevitt MC et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72-75.
28. Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR. Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Re search Group. Ann Intern Med 1991; 115: 837-842.
29. De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross sectional analysis. Brit Med J 1997; 315(7102): 221-225.
30. No authors listed. Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002; 17 (4): 716-724.
31. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11(7): 1010-1018.
32. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878-882.
33. Israeli RS, Ryan CW, Jung LL. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol 2008; 179(2): 414-423.
34. López AM, Pena MA, Hernandez R, Val F, Martin B, Riancho JA. Fracture risk in patients with prostate cancer on androgen deprivation therapy Osteoporos Int 2005; 16(6): 707-711.
35. Smith MR, Finkelstein JS, McGovern FJ et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002; 87: 599-603.
36. Yaturu S, DjeDjos S, Alferos G, Deprisco C. Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy. Prostate Cancer Prostatic Dis 2006; 9(1): 35-38.